| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |